Infliximab for the treatment of rheumatoid arthritis.
BACKGROUND: Infliximab is a human murine chimeric anti-tumour necrosis factor alpha monoclonal antibody recently approved for the treatment of refractory RA. OBJECTIVES: To assess the efficacy and safety of infliximab for the treatment of rheumatoid arthritis. SEARCH STRATEGY: Electronic databases...
Main Authors: | Blumenauer, B, Judd, M, Wells, G, Burls, A, Cranney, A, Hochberg, M, Tugwell, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2002
|
Similar Items
-
Etanercept for the treatment of rheumatoid arthritis.
by: Blumenauer, B, et al.
Published: (2003) -
Etanercept for the treatment of rheumatoid arthritis
by: Blumenauer, B, et al.
Published: (2004) -
Etanercept for the treatment of rheumatoid arthritis.
by: Lethaby, A, et al.
Published: (2013) -
Infliximab and methotrexate in the treatment of rheumatoid arthritis
by: Lipsky, P, et al.
Published: (2000) -
The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation.
by: Jobanputra, P, et al.
Published: (2002)